RYTM Rhythm Pharmaceuticals, Inc. | US76243J1051
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 7.003.403.776 | 5.952.669.039,03 | 7.193.657.621,37 | 6.734.424.793,78 |
| Enterprise Value | 6.883.572.224 | 5.894.371.039,03 | 7.143.348.621,37 | 6.686.485.793,78 |
| Trailing P/E | - | - | - | - |
| Forward P/E | -138,52 | - | - | - |
| Price to Sales | 32,25 | 27,41 | 37,91 | 50,82 |
| Price to Book | 56,85 | 25,05 | 26,64 | 22,78 |
| EV/Revenue | 31,7 | 27,14 | 37,64 | 50,46 |
| EV/EBITDA | -35,09 | - | - | - |